Biotech Investments Fueling the Blood Grouping Reagents Market Growth
The Blood Grouping Reagents Market is growing rapidly due to increasing investments by biotechnology and diagnostic companies. Funding is being channeled into research and development for advanced reagent formulations and automated blood typing platforms.
These investments improve efficiency, reduce errors, and enable high-throughput testing in hospitals and blood banks. Strategic collaborations between biotech firms and healthcare providers are also driving product innovation and market expansion.
Market Outlook: Valued at USD 1.2 billion in 2024, the market is projected to reach USD 2.5 billion by 2034, growing at a 7.1% CAGR.